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GABAA receptors (GABAARs) mediate the majority of fast inhibition in the CNS and as 
such are crucial to neuronal function. Two distinct modes of GABAAR mediated 
inhibition exist: “phasic” involves the transient activation of postsynaptic GABAARs 
following presynaptic vesicular GABA release and “tonic” whereby high-affinity 
extrasynaptic GABAARs are persistently activated by ambient GABA. GABAARs 
exhibit a rich pharmacology and are the target for a number of clinically useful 
compounds including benzodiazepines, barbiturates and certain general anaesthetics. In 
addition, several naturally occurring steroids typified by the progesterone metabolite 5α-
pregnan-3α-ol-20-one (5α3α) are potent positive allosteric modulators of GABAAR 
function - a property that endows these steroids with anxiolytic, sedative and anti-
convulsant actions. Importantly, in addition to importing steroids from the periphery, 
the brain also harbours a steroidogenic capacity and can manufacture GABA-
modulatory steroids, termed “neurosteroids”, from cholesterol. Although several studies 
have demonstrated neurosteroids to be implicated in a variety of physiological processes 
including neurodevelopment, important questions remain. In particular, are 
neurosteroids neurone selective? Do they discriminate between particular neuronal 
GABAARs subtypes? Under what conditions do endogenous neurosteroids influence 
neuronal function? And importantly, which cells synthesise neurosteroids in the central 
nervous system?  
 Therefore, the principal aims of this study were: 1) to characterise the properties 
of GABAAR mediated inhibition in postnatal day (P) 17-24 neurones of the mouse 
ventrobasal (VB) nucleus of the thalamus – neurones which have a well defined 
GABAAR expression profile and which exhibit both synaptic and tonic GABAAR 
mediated inhibition. 2) To investigate the effects of 5α3α on synaptic and tonic 
GABAAR mediated inhibition in VB neurones. 3) To investigate whether there is a role 
for endogenous neurosteroids in regulating synaptic GABAAR function during postnatal 
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development (P7-P20) in VB neurones and 4) cortical layer 2/3 neurones – a neuronal 
population with a more heterogenous, and less well defined GABAAR expression 
profile.  
 To address these aims, whole-cell voltage clamp recordings were performed on 
acute brain slices derived from wild type and transgenic GABAAR subunit “knock-out” 
mice in conjunction with pharmacological approaches. Synaptic inhibition in WT VB 
neurones, as inferred by recording miniature inhibitory postsynaptic currents (mIPSCs) 
was characterised by relatively large amplitude and fast decaying mIPSCs. A large tonic 
conductance in WT VB neurones was inhibited following application of the competitive 
GABAAR antagonist bicuculline (30 µM). Deletion of the α4 subunit (α4
0/0
) revealed 
alteration to both synaptic and tonic inhibition. Most notably, α4
0/0 
VB neurones 
displayed a greatly diminished tonic conductance. These results are in agreement that 
the majority of extrasynaptic GABAARs in VB neurones contain the α4 subunit. 
Exogenous application of the neurosteroid 5α3α (100 nM) to WT VB neurones only 
modestly enhanced the tonic conductance and also gave rise to mIPSCs with prolonged 
decay kinetics. It is concluded 5α3α has a relatively low potency at the extrasynaptic 
GABAAR population in VB neurones and furthermore that this concentration does not 
discriminate between synaptic and tonic inhibition. 
 Between P7 and P20, mIPSCs recorded from VB and L2/3 neurones became 
progressively faster decaying, a feature that has been associated with an increase in α1-
GABAAR subunit expression during development. However, the developmental 
decrease in mIPSC decay time was still observed in recordings from α1
0/0 
L2/3 
pyramidal neurones indicating the contribution of additional factors. Here I show that 
blocking neurosteroid synthesis using the 5α-reductase inhibitor, finasteride, or treating 
the brain slice with the steroid-scavenger molecule, γ-cyclodextrin (γ-CD), results in 
significantly faster mIPSC decay times between P7 and P10 in VB and L2/3 neurones. 
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These results provide the first indication that an endogenous neurosteroid tone may 
influence the mIPSC decay kinetics of VB and L2/3 neurones during development. 
Moreover, compared to γ-CD pre-incubation, application of γ-CD to the intracellular 
compartment via the patch pipette was found to be equally effective thus suggesting a 
possible autocrine mechanism of neurosteroid action. For VB neurones at P20-24 (an 
age range at which the mIPSCs are insensitive to γ-CD treatment), incubation with the 
GABAAR-inactive neurosteroid precursor 5α-DHP resulted in a robust prolongation of 
the mIPSC decay time thus revealing the presence of functional neurosteroidogenic 
enzymes in the brain slice tissue.       
In summary, these results reveal for the first time that during the first ~2 weeks 
of life the developmental decrease in the duration of the mIPSCs recorded from VB and 
L2/3 neurones is largely due to a reduction in local neurosteroid synthesis. Moreover, 
P20-24 VB neurones are capable of reinitiating neurosteroid production thus giving rise 
to a mechanism that may, under certain conditions, locally influence neuronal 
inhibition. These results may have important physiological consequences as the 
developmental timing of the neurosteroid tone observed here coincides with a myriad of 
crucial neurodevelopmental processes including the transition of GABA from a 













The aims of this project were: 
 
• To characterise the properties of both the mIPSCs (mediated by synaptic 
GABAARs) and the tonic conductance (mediated by extrasynaptic GABAARs) in 
VB neurones. These studies were performed using the whole cell patch clamp 





•  To compare the effects of DS2, THIP and the neurosteroid 5α3α on synaptic 
vsextrasynaptic GABAARs in P17-24 VB neurones derived from WT and 
GABAAR subunit “knock-out” mice.   
 
• To investigate the possibility that endogenous neurosteroid levels regulate 
synaptic GABAAR function during postnatal development (P7-P20) in VB 
neurones. 
 
• To investigate the possibility that endogenous neurosteroid levels regulate 
synaptic GABAAR function during postnatal development (P7-P20) in cortical 
layer L2/3 pyramidal neurones and L2/3 cortical interneurones.  
 
 
 
 
 
